Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 361

1.

Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.

Zamecnik J, Snuderl M, Eckschlager T, Chanova M, Hladikova M, Tichy M, Kodet R.

Mod Pathol. 2003 Oct;16(10):980-91.

PMID:
14559980
[PubMed - indexed for MEDLINE]
Free Article
2.

Prognostic factors in intracranial ependymomas in children.

Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, Lena G, Choux M, Pellissier JF.

J Neurosurg. 2000 Oct;93(4):605-13.

PMID:
11014538
[PubMed - indexed for MEDLINE]
3.

Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.

Korshunov A, Golanov A, Timirgaz V.

J Neurol Sci. 2000 Aug 1;177(1):72-82.

PMID:
10967185
[PubMed - indexed for MEDLINE]
4.

Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.

Prayson RA.

Ann Diagn Pathol. 1999 Feb;3(1):11-8.

PMID:
9990108
[PubMed - indexed for MEDLINE]
5.

Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.

Kurt E, Zheng PP, Hop WC, van der Weiden M, Bol M, van den Bent MJ, Avezaat CJ, Kros JM.

Cancer. 2006 Jan 15;106(2):388-95.

PMID:
16342252
[PubMed - indexed for MEDLINE]
Free Article
6.

The clinical and prognostic relevance of grading in intracranial ependymomas.

Ernestus RI, Schröder R, Stützer H, Klug N.

Br J Neurosurg. 1997 Oct;11(5):421-8.

PMID:
9474274
[PubMed - indexed for MEDLINE]
7.

Immunohistochemical markers for prognosis of ependymal neoplasms.

Korshunov A, Golanov A, Timirgaz V.

J Neurooncol. 2002 Jul;58(3):255-70.

PMID:
12187959
[PubMed - indexed for MEDLINE]
8.

Flow cytometric DNA analysis of pediatric intracranial ependymomas.

Kotylo PK, Robertson PB, Fineberg NS, Azzarelli B, Jakacki R.

Arch Pathol Lab Med. 1997 Dec;121(12):1255-8.

PMID:
9431314
[PubMed - indexed for MEDLINE]
9.

Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.

Prayson RA.

Am J Clin Pathol. 1998 Nov;110(5):629-34.

PMID:
9802348
[PubMed - indexed for MEDLINE]
10.

Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma.

Wolfsberger S, Fischer I, Höftberger R, Birner P, Slavc I, Dieckmann K, Czech T, Budka H, Hainfellner J.

Am J Surg Pathol. 2004 Jul;28(7):914-20.

PMID:
15223962
[PubMed - indexed for MEDLINE]
11.

Intracranial ependymomas of childhood: long-term outcome and prognostic factors.

Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shultz B, Albright AL, Janosky J, Deutsch M.

Neurosurgery. 1995 Oct;37(4):655-66; discussion 666-7.

PMID:
8559293
[PubMed - indexed for MEDLINE]
12.

A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma.

Ho DM, Hsu CY, Wong TT, Chiang H.

J Neurooncol. 2001 Aug;54(1):77-85.

PMID:
11763426
[PubMed - indexed for MEDLINE]
13.

[Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors].

Figarella-Branger D, Metellus P, Barrié M, Maues de Paula A, Fernandez C, Polivka M, Vital A, Labrousse F, Vignaud JM, Laquerrière A, Rousselet MC, Lacroix C, Saikali S, Chapon F, Gontier MF, Chrétien F, Babin P, Rigau V, Vandenbos F, Peoc'h M, Kujas M, Chinot O, Gouvernet J, Giorgi R, Guyotat J, Jouvet A.

Neurochirurgie. 2007 Jun;53(2-3 Pt 1):76-84. French.

PMID:
17445840
[PubMed - indexed for MEDLINE]
14.

Prognostic relevance of localization and grading in intracranial ependymomas of childhood.

Ernestus RI, Schröder R, Stützer H, Klug N.

Childs Nerv Syst. 1996 Sep;12(9):522-6.

PMID:
8906366
[PubMed - indexed for MEDLINE]
15.

Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors.

Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Di Carlo L, Semeraro A, Daddi G, Darwish S, Stocchi L, Tofanetti FR, Bellezza G, Sidoni A, Tognellini R, Crinò L, Tonato M.

Tumori. 2008 May-Jun;94(3):398-405.

PMID:
18705409
[PubMed - indexed for MEDLINE]
16.

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR Jr, Milstein JM, Packer RJ, Wisoff J.

J Neurosurg. 1998 Apr;88(4):695-703.

PMID:
9525716
[PubMed - indexed for MEDLINE]
17.

The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors.

Tihan T, Zhou T, Holmes E, Burger PC, Ozuysal S, Rushing EJ.

Mod Pathol. 2008 Feb;21(2):165-77. Epub 2007 Dec 14.

PMID:
18084249
[PubMed - indexed for MEDLINE]
Free Article
18.

Intracranial ependymomas: analysis of prognostic factors in a population-based series.

Foreman NK, Love S, Thorne R.

Pediatr Neurosurg. 1996;24(3):119-25.

PMID:
8870014
[PubMed - indexed for MEDLINE]
19.

Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial: multivariate analysis with Ki-67 index, mitotic count, and microvessel density.

Mandard AM, Denoux Y, Herlin P, Duigou F, van De Vijver MJ, Clahsen PC, van Den Broek L, Sahmoud TM, Henry-Amar M, van De Velde CJ.

Cancer. 2000 Oct 15;89(8):1748-57.

PMID:
11042570
[PubMed - indexed for MEDLINE]
20.

MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.

Neder L, Colli BO, Machado HR, Carlotti CG Jr, Santos AC, Chimelli L.

Clin Neuropathol. 2004 Nov-Dec;23(6):262-70.

PMID:
15584210
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk